bluebird bio, Inc Earning Date (BLUE)

USA |NASDAQ |USD

BLUE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 21, 2022 Dec 2021 $-2.02 $-3.16 $-3.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 21, 2022 Dec 2021 $8.25M $22.68M $10.71M

Bluebird Bio, Inc's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 2021.

BLUE Earnings Date & History Chart

BLUE Earnings & Revenue Forecast

BLUE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 13 $-2.02 $-3.07 $-1.11
Mar 2022 9 $-1.73 $-2.71 $-1.36
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-11.70 $-13.05 $-10.90
Dec 2022 16 $-6.23 $-11.14 $-1.90

BLUE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 12 / 0 $-2.79 $-2.79 $-2.77
Mar 2022 8 / 0 $-2.60 $-2.61 $-2.50
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 6 / 3 $-12.10 $-12.09 $-12.03
Dec 2022 14 / 0 $-9.21 $-9.20 $-9.43

BLUE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $8.25M $0.00 $41.00M
Mar 2022 7 $7.66M $0.00 $28.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $52.71M $42.90M $88.00M
Dec 2022 14 $38.88M $0.00 $125.00M

BLUE Earnings Date & Revenue History

BLUE Earnings History

|
Show More
Show More

BLUE Revenue History

|
Show More
Show More

Bluebird Bio, Inc Next Earnings Date & Report

BLUE Next Earnings Date & Report Preview: Dec 2021 (FQ)

BLUE's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 13 analysts, the average EPS estimation for Bluebird Bio, Inc's next quarterly earnings is $-2.02, with a low EPS estimation of $-3.07, and a high estimation of $-1.11.

Over the last 1 month, EPS estimates have seen 12 upward revisions and 0 downward. The EPS 1 month trend is $-2.79, the last 2 month trend is $-2.79, and the 3 month trend is $-2.77.

Based on 14 analysts, the average revenue estimation is $8.25M, with a low revenue estimation of $0.00, and a high estimation of $41.00M.

Bluebird Bio, Inc Previous Earnings Dates & Reports

BLUE Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Bluebird Bio, Inc's previous earnings date was Nov 5, 2021 for its fiscal quarter ended Sep 30, 2021.

BLUE's earnings per share (EPS) was $-3.16, missing the consensus analysts forecast of $-2.52 by -25.57%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -11.73%, and lower than the same period a year before (Sep 2020) by 7.48%.

Revenues were $22.68M, worse than the forecast of $35.44M by -36.01%, up by 203.49% from the previous quarter , and up by 17.66% from the same period last year.

The company reported a net income of $-216.82M.

Free cash flow for the quarter was $-156.68M , compared to $-149.23M last quarter and $-154.40M a year before.

BLUE ended the quarter with $181.57M in total debt, a decrease of -8.58% compared to the previous quarter, and a decrease of -7.03% compared to the same quarter a year before.

BLUE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bluebird Bio, Inc's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

BLUE's earnings per share (EPS) was $-9.95, missing the consensus analysts forecast of $-9.79 by 1.63% , and higher than the previous year's EPS (Dec 2019) by -30.47%.

Revenues were $250.73M, worse than the forecast of $259.07M by -3.22%, and up by 461.25% from previous year's revenue.

The company reported a net income of $-618.70M.

Bluebird Bio, Inc reported a free cash flow of $-499.34M for its fiscal year, compared to $-640.64M a year ago.

The company ended the fiscal year with $193.02M in total debt, an increase of 1.06% compared to the previous year.